Cipollone v. Liggett Group, Inc.

112 S. Ct. 2608, 120 L. Ed. 2d 407, 6 Fla. L. Weekly Fed. S 589, 505 U.S. 504, 17 U.C.C. Rep. Serv. 2d (West) 1087, 92 Daily Journal DAR 8688, 1992 U.S. LEXIS 4365, 60 U.S.L.W. 4703, 92 Cal. Daily Op. Serv. 5517
Supreme Court of the United States·Decided June 24, 1992·No. 90-1038·Published·Cited by 2,607 cases

Opinions

[508]*508Justice Stevens

delivered the opinion of the Court, except as to Parts V and VI.

“Warning: The Surgeon General Has Determined That Cigarette Smoking Is Dangerous to Your Health.” A federal statute enacted in 1969 requires that warning (or a variation thereof) to appear in a conspicuous place on every package of cigarettes sold in the United States.1 The questions presented to us by this case are whether that statute, or its 1965 predecessor which required a less alarming label, pre-empted petitioner’s common-law claims against respondent cigarette manufacturers.

Petitioner is the son of Rose Cipollone, who began smoking in 1942 and who died of lung cancer in 1984. He claims that respondents are responsible for Rose Cipollone’s death because they breached express warranties contained in their advertising, because they failed to warn consumers about the hazards of smoking, because they fraudulently misrepresented those hazards to consumers, and because they conspired to deprive the public of medical and scientific information about smoking. The Court of Appeals held that petitioner’s state-law claims were pre-empted by federal statutes, 893 F. 2d 541 (CA3 1990), and other courts have agreed with that analysis.2 The highest court of the State of New Jersey, however, has held that the federal statutes [509]*509did not pre-empt similar common-law claims.3 Because of the manifest importance of the issue, we granted certiorari to resolve the conflict, 499 U. S. 935 (1991). We now reverse in part and affirm in part.

I

On August 1,1983, Rose Cipollone and her husband filed a complaint invoking the diversity jurisdiction of the Federal District Court. Their complaint alleged that Rose Cipollone developed lung cancer because she smoked cigarettes manufactured and sold by the three respondents. After her death in 1984, her husband filed an amended complaint. After trial, he also died; their son, executor of both estates, now maintains this action.

Petitioner’s third amended complaint alleges several different bases of recovery, relying on theories of strict liability, negligence, express warranty, and intentional tort. These claims, all based on New Jersey law, divide into five categories. The “design defect claims” allege that respondents’ cigarettes were defective because respondents failed to use a safer alternative design for their products and because the social value of their product was outweighed by the dangers it created (Count 2, App. 83-84). The “failure to warn claims” allege both that the product was “defective as a result of [respondents’] failure to provide adequate warnings of the health consequences of cigarette smoking” (Count 3, App. 85) and that respondents “were negligent in the manner [that] they tested, researched, sold, promoted and advertised” their cigarettes (Count 4, App. 86). The “express warranty claims” allege that respondents had “expressly [510]*510warranted that smoking the cigarettes which they manufactured and sold did not present any significant health consequences” (Count 7, App. 88). The “fraudulent misrepresentation claims” allege that respondents had willfully, “through their advertising, attempted to neutralize the [federally mandated] warnin[g]” labels (Count 6, App. 87-88), and that they had possessed, but had “ignored and failed to act upon,” medical and scientific data indicating that “cigarettes were hazardous to the health of consumers” (Count 8, App. 89). Finally, the “conspiracy to defraud claims” allege that respondents conspired to deprive the public of such medical and scientific data (ibid.).

As one of their defenses, respondents contended that the Federal Cigarette Labeling and Advertising Act, enacted in 1965, and its successor, the Public Health Cigarette Smoking Act of 1969, protected them from any liability based on their conduct after 1965. In a pretrial ruling, the District Court concluded that the federal statutes were intended to establish a uniform warning that would prevail throughout the country and that would protect cigarette manufacturers from being “subjected to varying requirements from state to state,” Cipollone v. Liggett Group, Inc., 593 F. Supp. 1146, 1148 (NJ 1984), but that the statutes did not pre-empt common-law actions. Id., at 1153-1170.4 Accordingly, the court granted a motion to strike the pre-emption defense entirely.

[511]*511The Court of Appeals accepted an interlocutory appeal pursuant to 28 U. S. C. § 1292(b), and reversed. Cipollone v. Liggett Group, Inc., 789 F. 2d 181 (CA3 1986). The court rejected respondents’ contention that the federal Acts expressly pre-empted common-law actions, but accepted their contention that such actions would conflict with federal law. Relying on the statement of purpose in the statutes,5 the court concluded that Congress’ “carefully drawn balance between the purposes of warning the public of the hazards of cigarette smoking and protecting the interests of national economy” would be upset by state-law damages actions based on noncomplianee with “warning, advertisement, and promotion obligations other than those prescribed in the [federal] Act.” Id., at 187. Accordingly, the court held:

“[T]he Act preempts those state law damage[s] actions relating to smoking and health that challenge either the adequacy of the warning on cigarette packages or the propriety of a party’s actions with respect to the advertising and promotion of cigarettes. [W]here the success of a state law damage[s] claim necessarily depends on the assertion that a party bore the duty to provide a warning to consumers in addition to the warning Congress has required on cigarette packages, such claims are preempted as conflicting with the Act.” Ibid, (footnote omitted).

[512]*512The court did not, however, identify the specific claims asserted by petitioner that were pre-empted by the Act.

This Court denied a petition for certiorari, 479 U. S. 1043 (1987), and the ease returned to the District Court for trial. Complying with the Court of Appeals’ mandate, the District Court held that the failure-to-warn, express-warranty, fraudulent-misrepresentation, and conspiraey-to-defraud claims were barred to the extent that they relied on respondents’ advertising, promotional, and public relations activities after January 1, 1966 (the effective date of the 1965 Act). 649 F. Supp. 664, 669, 673-675 (NJ 1986). The court also ruled that while the design defect claims were not pre-empted by federal law, those claims were barred on other grounds.6 Id., at 669-672. Following extensive discovery and a 4-month trial, the jury answered a series of special interrogatories and awarded $400,000 in damages to Rose Cipollone’s husband. In brief, it rejected all of the fraudulent-misrepresentation and conspiracy claims, but found that respondent Liggett had breached its duty to warn and its express warranties before 1966. It found, however, that Rose Cipollone had “Voluntarily and unreasonably encountered] a known danger by smoking cigarettes’ ” and that 80% of the responsibility for her injuries was attributable to her. See 893 F. 2d, at 554 (summarizing jury findings). For that reason, no damages were awarded to her estate.

Free access — add to your briefcase to read the full text and ask questions with AI

Cipollone v. Liggett Group, Inc., 112 S. Ct. 2608, 120 L. Ed. 2d 407, 6 Fla. L. Weekly Fed. S 589, 505 U.S. 504, 17 U.C.C. Rep. Serv. 2d (West) 1087, 92 Daily Journal DAR 8688, 1992 U.S. LEXIS 4365, 60 U.S.L.W. 4703, 92 Cal. Daily Op. Serv. 5517 (U.S. 1992).

112 S. Ct. 2608 (Cipollone v. Liggett Group, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

State v. CSX Transp., Inc.
2022 Ohio 2832 (Ohio Supreme Court, 2022)
Arizona Dream Act Coalition v. Janice Brewer
855 F.3d 957 (Ninth Circuit, 2017)
Boros v. Pfizer, Inc.
Superior Court of Delaware, 2016
Untitled Texas Attorney General Opinion
Texas Attorney General Reports, 2012
Willis v. Winters
234 P.3d 141 (Court of Appeals of Oregon, 2010)
U.S. Smokeless Tobacco Manufacturing Co. v. City of New York
703 F. Supp. 2d 329 (S.D. New York, 2010)
Chae v. SLM Corp.
593 F.3d 936 (Ninth Circuit, 2010)
Wright v. General Electric Co.
242 S.W.3d 674 (Court of Appeals of Kentucky, 2007)
Craft v. Graebel-Oklahoma Movers, Inc.
2007 OK 79 (Supreme Court of Oklahoma, 2007)
Souther v. Eli Lilly & Co.
489 F. Supp. 2d 230 (E.D. New York, 2007)
Frith v. Bic Corporation
863 So. 2d 960 (Mississippi Supreme Court, 2004)
Waterhouse v. R.J. Reynolds Tobacco Co.
270 F. Supp. 2d 678 (D. Maryland, 2003)
United States v. Philip Morris Inc.
263 F. Supp. 2d 72 (District of Columbia, 2003)
Estate of Alicano Ayala v. Phillip Morris, Inc.
263 F. Supp. 2d 311 (D. Puerto Rico, 2003)
Forest Park II v. Hadley
203 F. Supp. 2d 1071 (D. Minnesota, 2002)
Guckenberg v. Wisconsin Central Ltd.
178 F. Supp. 2d 954 (E.D. Wisconsin, 2001)